Follow us for updates
© 2020
Read the Story →

Aching for Back to Normal? Wait Until 2022, Says WHO Scientist

There is not enough supply of vaccines.
Sep 17, 2020

A return to normal life before COVID-19 may not be possible until 2022 due to a short supply of vaccines, the chief scientist of the World Health Organization told the South China Morning Post.

The prediction from the WHO's Soumya Swaminathan came as much of the west was guarding against a second wave and while hard-hit developing countries began to see signs that infections were going down. In the Philippines, authorities expect to flatten the curve by the end of September.

Vaccine production will be too small and will not reach the target 2 billion by the end of 2021. That's the threshold scientists are looking at to forego the need for face masks and physical distancing, Swaminathan said.

Duterte Says Virus Still Lurks, So Keep Your Guard Up as Curve Flattens
Flattening of the Curve Within Sight, Don't Relax Just Yet

Swaminatahan was referring to the WHO's COVAX vaccine initiative, which he said could pool hundreds of millions of doses by mid-2021. Some 170 countries under the initiative "will have something." The Philippines is a part of COVAX.

Continue reading below ↓

“The way that people are picturing it is that in January you have vaccines for the whole world and things will start going back to normal – it is not how it works,” she said.

“Our best assessment [for vaccine roll-out] is the middle of 2021 because at the beginning of 2021 is when you will start seeing the results of some of these trials.”

Volunteers Wanted: What to Expect from COVID Vaccine Trials
Keep on Zoom-Drinking: Vaccine-Hunter Says Keep Safe While Waiting

President Rodrigo Duterte said Monday he would "give preference" to COVID-19 vaccines by Russia and China as long as they would be proven effective. He also said western drugmakers "must be crazy" for asking for a reservation fee for their own vaccines.

The Philippines is preparing for phase three human trials on COVID-19 vaccines. This is the last stage before commecial availability.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.